218 related articles for article (PubMed ID: 11505068)
1. Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma.
Esnaola NF; Rubin BP; Baldini EH; Vasudevan N; Demetri GD; Fletcher CD; Singer S
Ann Surg; 2001 Aug; 234(2):215-23. PubMed ID: 11505068
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma.
Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH
Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519
[TBL] [Abstract][Full Text] [Related]
3. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
[TBL] [Abstract][Full Text] [Related]
4. Optimal management strategies for rhabdomyosarcoma in children.
Walterhouse D; Watson A
Paediatr Drugs; 2007; 9(6):391-400. PubMed ID: 18052409
[TBL] [Abstract][Full Text] [Related]
5. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Yu L; Wang J
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
[TBL] [Abstract][Full Text] [Related]
6. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
7. Treatment of adult rhabdomyosarcoma.
Ogilvie CM; Crawford EA; Slotcavage RL; King JJ; Lackman RD; Hartner L; Staddon AP
Am J Clin Oncol; 2010 Apr; 33(2):128-31. PubMed ID: 19770626
[TBL] [Abstract][Full Text] [Related]
8. [Local therapy of Ewing sarcoma: radiotherapy aspects].
Dunst J; Jabar S; Paulussen M; Jürgens H
Klin Padiatr; 1994; 206(4):277-81. PubMed ID: 7967424
[TBL] [Abstract][Full Text] [Related]
9. The changing role of surgery in the management of rhabdomyosarcoma.
Connolly B; Staines A; O'Meara A; Breatnach F; Fitzgerald RJ
Eur J Pediatr Surg; 1992 Apr; 2(2):90-3. PubMed ID: 1610758
[TBL] [Abstract][Full Text] [Related]
10. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma.
Weigel BJ; Breitfeld PP; Hawkins D; Crist WM; Baker KS
J Pediatr Hematol Oncol; 2001; 23(5):272-6. PubMed ID: 11464981
[TBL] [Abstract][Full Text] [Related]
11. [A infant case of rhabdomyosarcoma arising from the left iliac region with complete remission for 2 years after combination therapy].
Shimabuku M; Muto Y; Hokama A; Tokumine F; China K; Gushiken T; Sonan S; Hirayama K; Toda T
Gan To Kagaku Ryoho; 1993 Apr; 20(5):657-60. PubMed ID: 8470926
[TBL] [Abstract][Full Text] [Related]
12. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
[TBL] [Abstract][Full Text] [Related]
13. Childhood rhabdomyosarcoma of the trunk and extremities.
Tabrizi P; Letts M
Am J Orthop (Belle Mead NJ); 1999 Aug; 28(8):440-6. PubMed ID: 10470666
[TBL] [Abstract][Full Text] [Related]
14. Conservative management of uterine pediatric rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study III and IV pilot.
Corpron CA; Andrassy RJ; Hays DM; Raney RB; Wiener ES; Lawrence W; Lobe TE; Maurer HM
J Pediatr Surg; 1995 Jul; 30(7):942-4. PubMed ID: 7472949
[TBL] [Abstract][Full Text] [Related]
15. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Burke M; Anderson JR; Kao SC; Rodeberg D; Qualman SJ; Wolden SL; Meyer WH; Breitfeld PP;
J Clin Oncol; 2007 Nov; 25(31):4909-13. PubMed ID: 17971587
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy.
Kojima Y; Hashimoto K; Ando M; Yonemori K; Hirakawa A; Kodaira M; Yunokawa M; Shimizu C; Tamura K; Katsumata N; Hosono A; Makimoto A; Fujiwara Y
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1249-57. PubMed ID: 22441933
[TBL] [Abstract][Full Text] [Related]
18. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors.
Wessalowski R; Schneider DT; Mils O; Hannen M; Calaminus G; Engelbrecht V; Pape H; Willers R; Engert J; Harms D; Göbel U
Klin Padiatr; 2003; 215(6):303-9. PubMed ID: 14677093
[TBL] [Abstract][Full Text] [Related]
19. Local failure in childhood rhabdomyosarcoma and undifferentiated sarcoma: prognostic factors and implications for curative therapy.
Mameghan H; Fisher R; Tobias V; Kern IB; O'Gorman-Hughes D; Vowels M; Mameghan J
Med Pediatr Oncol; 1993; 21(2):88-95. PubMed ID: 8433684
[TBL] [Abstract][Full Text] [Related]
20. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
